Screening diabetes using sensors
A podcast on the use of metal oxide-based chemiresistive gas sensors to screen diabetes.
At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
Our expert, committed team put our shared values into action – every day. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
We are a digital transformation and technology partner of choice for industry-leading organizations worldwide.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
At TCS, we help enterprises grow through innovative solutions globally. Adapt and thrive with us.
A podcast on the use of metal oxide-based chemiresistive gas sensors to screen diabetes.
You have these already downloaded
We have sent you a copy of the report to your email again.
Sanjay Kimbahune, senior scientist at TCS Research and Dr Prasanta Kumar Guha, associate professor at IIT-Kharagpur, discuss how digital health sensors can screen diabetes and pave the way toward accessible healthcare.
About 537 million people between the ages 20-79 years are living with diabetes across the globe, as of 2021. Of these, almost half are undiagnosed. The number of people living with diabetes is predicted to rise to 643 million by 2030.
In this podcast, on November 14, World Diabetes Day, Sanjay Kimbahune, Senior Scientist at TCS Research and Dr. Prasanta Kumar Guha, Associate Professor at IIT-Kharagpur, discuss how digital health sensors can be used to screen non-communicable diseases, such as diabetes, unobtrusively and how they can pave the way toward accessible healthcare.
The experts breakdown their collaborative research on metal oxide-based chemiresistive gas sensors that are used to analyze and differentiate between volatile organic compounds (VOCs). Read more in their joint publication here. These VOCs are present in human breath and can be treated as biomarkers associated with specific diseases, making them useful in clinical diagnosis. Listen in.
Leveraging AI-powered model for crypto money laundering detection
Ecosystem Modeling in a Digitally Simulated Electricity Market
Empowering Forest Landowners to Measure and Monetize Carbon Credits
A Journey from Software Development to Visual Intelligence Research